Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 977 | 1025 | 1010 | 1226 | 1280 | 1618 |
Fund Return | -2.33% | 2.54% | 1% | 7.02% | 5.06% | 4.93% |
Place in category | 378 | 322 | 179 | 199 | 113 | 73 |
% in Category | 74 | 63 | 35 | 44 | 29 | 28 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UK Equity Income Fund Institutional | 90.47M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Z Accumulatio | 662.88M | 10.40 | 7.25 | 7.07 | ||
UK Equity Income Fund Z Income GBP | 633.9M | 10.41 | 7.25 | 7.08 | ||
UK Equity Income Fund Retail Accumu | 115.35M | 6.42 | 5.43 | 5.94 | ||
TE Institutional Accumulation GBP | 163.15M | 5.50 | 7.78 | 9.42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 2.03B | 9.76 | 7.75 | 6.86 | ||
TB Evenlode Income B Income | 3.27B | 1.89 | 4.27 | 8.35 | ||
UK Equity Income Fund Institutional | 90.47M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Z Accumulatio | 662.88M | 10.40 | 7.25 | 7.07 | ||
UK Equity Income Fund Z Income GBP | 633.9M | 10.41 | 7.25 | 7.08 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Imperial Brands | GB0004544929 | 6.91 | 2,503.00 | -0.44% | |
GSK plc | GB00BN7SWP63 | 5.66 | 1,309.50 | +0.73% | |
HSBC | GB0005405286 | 4.87 | 726.00 | +0.48% | |
Unilever | GB00B10RZP78 | 4.70 | 54.36 | -0.33% | |
Pearson | GB0006776081 | 4.41 | 1,193.50 | +0.13% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Neutral | Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Neutral | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review